Another China Player To Watch? Sinocare Targets US Diabetes Market With Nipro Diagnostics
Sinocare Group, a Chinese specialist in biosensor-based blood glucose monitoring devices, is expanding into the US market after agreeing to buy Nipro Corporation’s diabetes business, Nipro Diagnostics. Sinocare gains US manufacturing sites and a ready-made US sales team in the deal, and the move could mark an important turning point in the company's internationalization strategy.
Register for our free email digests: